NEWLatest News


Califf: FDA will be a ‘more activist’ agency

August 31st, 2023|Comments Off on Califf: FDA will be a ‘more activist’ agency

Regulatory Focus - Aug. 24, 2023 Note: This article describes an interview co-moderated by Catalyst CEO Nancy Myers, along with Tom Kraus, VP- Government Relations, American Society for Health-System Pharmacists. The webinar interview was sponsored by [...]

HHS Floats Trio of Drug Pricing Models, Some More Ambitious Than Others

February 24th, 2023|Comments Off on HHS Floats Trio of Drug Pricing Models, Some More Ambitious Than Others

AISHealth.com - February 23, 2023    Jeff Myers, Catalyst’s Senior Vice President, Market Access & Reimbursement Strategies, comments on the pricing models recently announced by CMS. Mr. Myers "says cell and gene therapy manufacturers may be skeptical [...]

NEWLatest Blog Posts and Op Eds


The Catalyst Team shows support on Rare Disease Day

February 29th, 2024|Comments Off on The Catalyst Team shows support on Rare Disease Day

Being rare is often a blessing: a rare gem stands out from a pile of stones, a rare talent can garner prestige and success, and a rare personality can make for an influential leader or [...]